196 related articles for article (PubMed ID: 12750176)
1. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.
Westervelt P; Lane AA; Pollock JL; Oldfather K; Holt MS; Zimonjic DB; Popescu NC; DiPersio JF; Ley TJ
Blood; 2003 Sep; 102(5):1857-65. PubMed ID: 12750176
[TBL] [Abstract][Full Text] [Related]
2. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
[TBL] [Abstract][Full Text] [Related]
3. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
[TBL] [Abstract][Full Text] [Related]
4. Expression of a bcr-1 isoform of RARalpha-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2.
Walter MJ; Ries RE; Armstrong JR; Park JS; Mardis ER; Ley TJ
Blood; 2007 Feb; 109(3):1237-40. PubMed ID: 17008533
[TBL] [Abstract][Full Text] [Related]
5. Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model.
Santana BA; Pintão MC; Abreu e Lima RS; Scheucher PS; Santos GA; Garcia AB; Falcão RP; Rego EM
Braz J Med Biol Res; 2006 May; 39(5):615-20. PubMed ID: 16648899
[TBL] [Abstract][Full Text] [Related]
6. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.
Grisolano JL; Wesselschmidt RL; Pelicci PG; Ley TJ
Blood; 1997 Jan; 89(2):376-87. PubMed ID: 9002938
[TBL] [Abstract][Full Text] [Related]
7. A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.
Pollock JL; Westervelt P; Kurichety AK; Pelicci PG; Grisolano JL; Ley TJ
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15103-8. PubMed ID: 10611345
[TBL] [Abstract][Full Text] [Related]
8. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
[TBL] [Abstract][Full Text] [Related]
10. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
[TBL] [Abstract][Full Text] [Related]
11. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
12. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
[TBL] [Abstract][Full Text] [Related]
13. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice.
Lane AA; Ley TJ
Cell; 2003 Oct; 115(3):305-18. PubMed ID: 14636558
[TBL] [Abstract][Full Text] [Related]
15. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.
Wojiski S; Guibal FC; Kindler T; Lee BH; Jesneck JL; Fabian A; Tenen DG; Gilliland DG
Leukemia; 2009 Aug; 23(8):1462-71. PubMed ID: 19322209
[TBL] [Abstract][Full Text] [Related]
16. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.
Walter MJ; Park JS; Lau SK; Li X; Lane AA; Nagarajan R; Shannon WD; Ley TJ
Mol Cell Biol; 2004 Dec; 24(24):10882-93. PubMed ID: 15572690
[TBL] [Abstract][Full Text] [Related]
18. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
19. [hCG-PLZF-RARalpha/hCG-RARalpha-PLZF transgenic mice developing into leukemia].
Chen LJ; Dong Y; Chen SY; Zhang L; Zhou GB; Chen B; Wang L; Chen Z; Chen SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):924-31. PubMed ID: 16403252
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of PML/RARalpha impairs myelopoiesis.
Early E; Moore MA; Kakizuka A; Nason-Burchenal K; Martin P; Evans RM; Dmitrovsky E
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7900-4. PubMed ID: 8755574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
